211 related articles for article (PubMed ID: 37556385)
41. Alpha-lipoic acid prevents mitochondrial damage and neurotoxicity in experimental chemotherapy neuropathy.
Melli G; Taiana M; Camozzi F; Triolo D; Podini P; Quattrini A; Taroni F; Lauria G
Exp Neurol; 2008 Dec; 214(2):276-84. PubMed ID: 18809400
[TBL] [Abstract][Full Text] [Related]
42. Neoline is the active ingredient of processed aconite root against murine peripheral neuropathic pain model, and its pharmacokinetics in rats.
Tanimura Y; Yoshida M; Ishiuchi K; Ohsawa M; Makino T
J Ethnopharmacol; 2019 Sep; 241():111859. PubMed ID: 30974202
[TBL] [Abstract][Full Text] [Related]
43. Orally active Epac inhibitor reverses mechanical allodynia and loss of intraepidermal nerve fibers in a mouse model of chemotherapy-induced peripheral neuropathy.
Singhmar P; Huo X; Li Y; Dougherty PM; Mei F; Cheng X; Heijnen CJ; Kavelaars A
Pain; 2018 May; 159(5):884-893. PubMed ID: 29369966
[TBL] [Abstract][Full Text] [Related]
44. Attenuation of nociceptive and paclitaxel-induced neuropathic pain by targeting inflammatory, CGRP and substance P signaling using 3-Hydroxyflavone.
Ullah R; Ali G; Subhan F; Naveed M; Khan A; Khan J; Halim SA; Ahmad N; Zakiullah ; Al-Harrasi A
Neurochem Int; 2021 Mar; 144():104981. PubMed ID: 33549629
[TBL] [Abstract][Full Text] [Related]
45. Dynamic long-term microstructural and ultrastructural alterations in sensory nerves of rats of paclitaxel-induced neuropathic pain.
Wu Y; Li J; Zhou J; Feng Y
Chin Med J (Engl); 2014; 127(16):2945-52. PubMed ID: 25131233
[TBL] [Abstract][Full Text] [Related]
46. Allopregnanolone prevents and suppresses oxaliplatin-evoked painful neuropathy: multi-parametric assessment and direct evidence.
Meyer L; Patte-Mensah C; Taleb O; Mensah-Nyagan AG
Pain; 2011 Jan; 152(1):170-181. PubMed ID: 21071147
[TBL] [Abstract][Full Text] [Related]
47. Characterisation of Immune and Neuroinflammatory Changes Associated with Chemotherapy-Induced Peripheral Neuropathy.
Makker PG; Duffy SS; Lees JG; Perera CJ; Tonkin RS; Butovsky O; Park SB; Goldstein D; Moalem-Taylor G
PLoS One; 2017; 12(1):e0170814. PubMed ID: 28125674
[TBL] [Abstract][Full Text] [Related]
48. A3 adenosine receptor agonist prevents the development of paclitaxel-induced neuropathic pain by modulating spinal glial-restricted redox-dependent signaling pathways.
Janes K; Esposito E; Doyle T; Cuzzocrea S; Tosh DK; Jacobson KA; Salvemini D
Pain; 2014 Dec; 155(12):2560-2567. PubMed ID: 25242567
[TBL] [Abstract][Full Text] [Related]
49. The contribution of satellite glial cells to chemotherapy-induced neuropathic pain.
Warwick RA; Hanani M
Eur J Pain; 2013 Apr; 17(4):571-80. PubMed ID: 23065831
[TBL] [Abstract][Full Text] [Related]
50. Increased α2δ-1-NMDA receptor coupling potentiates glutamatergic input to spinal dorsal horn neurons in chemotherapy-induced neuropathic pain.
Chen Y; Chen SR; Chen H; Zhang J; Pan HL
J Neurochem; 2019 Jan; 148(2):252-274. PubMed ID: 30431158
[TBL] [Abstract][Full Text] [Related]
51. Sustained Accumulation of Microtubule-Binding Chemotherapy Drugs in the Peripheral Nervous System: Correlations with Time Course and Neurotoxic Severity.
Wozniak KM; Vornov JJ; Wu Y; Nomoto K; Littlefield BA; DesJardins C; Yu Y; Lai G; Reyderman L; Wong N; Slusher BS
Cancer Res; 2016 Jun; 76(11):3332-9. PubMed ID: 27197173
[TBL] [Abstract][Full Text] [Related]
52. Induction of monocyte chemoattractant protein-1 (MCP-1) and its receptor CCR2 in primary sensory neurons contributes to paclitaxel-induced peripheral neuropathy.
Zhang H; Boyette-Davis JA; Kosturakis AK; Li Y; Yoon SY; Walters ET; Dougherty PM
J Pain; 2013 Oct; 14(10):1031-44. PubMed ID: 23726937
[TBL] [Abstract][Full Text] [Related]
53. Comparative Analysis of Chemotherapy-Induced Peripheral Neuropathy in Bioengineered Sensory Nerve Tissue Distinguishes Mechanistic Differences in Early-Stage Vincristine-, Cisplatin-, and Paclitaxel-Induced Nerve Damage.
Pollard KJ; Bolon B; Moore MJ
Toxicol Sci; 2021 Feb; 180(1):76-88. PubMed ID: 33410881
[TBL] [Abstract][Full Text] [Related]
54. Pharmacological SARM1 inhibition protects axon structure and function in paclitaxel-induced peripheral neuropathy.
Bosanac T; Hughes RO; Engber T; Devraj R; Brearley A; Danker K; Young K; Kopatz J; Hermann M; Berthemy A; Boyce S; Bentley J; Krauss R
Brain; 2021 Nov; 144(10):3226-3238. PubMed ID: 33964142
[TBL] [Abstract][Full Text] [Related]
55. Intravenous paclitaxel administration in the rat induces a peripheral sensory neuropathy characterized by macrophage infiltration and injury to sensory neurons and their supporting cells.
Peters CM; Jimenez-Andrade JM; Jonas BM; Sevcik MA; Koewler NJ; Ghilardi JR; Wong GY; Mantyh PW
Exp Neurol; 2007 Jan; 203(1):42-54. PubMed ID: 17005179
[TBL] [Abstract][Full Text] [Related]
56. Characterization of oxaliplatin-induced chronic painful peripheral neuropathy in the rat and comparison with the neuropathy induced by paclitaxel.
Xiao WH; Zheng H; Bennett GJ
Neuroscience; 2012 Feb; 203():194-206. PubMed ID: 22200546
[TBL] [Abstract][Full Text] [Related]
57. Peripheral Neuropathy Induced by Microtubule-Targeted Chemotherapies: Insights into Acute Injury and Long-term Recovery.
Wozniak KM; Vornov JJ; Wu Y; Liu Y; Carozzi VA; Rodriguez-Menendez V; Ballarini E; Alberti P; Pozzi E; Semperboni S; Cook BM; Littlefield BA; Nomoto K; Condon K; Eckley S; DesJardins C; Wilson L; Jordan MA; Feinstein SC; Cavaletti G; Polydefkis M; Slusher BS
Cancer Res; 2018 Feb; 78(3):817-829. PubMed ID: 29191802
[TBL] [Abstract][Full Text] [Related]
58. Ghrelin alleviates paclitaxel-induced peripheral neuropathy by reducing oxidative stress and enhancing mitochondrial anti-oxidant functions in mice.
Ishii N; Tsubouchi H; Miura A; Yanagi S; Ueno H; Shiomi K; Nakazato M
Eur J Pharmacol; 2018 Jan; 819():35-42. PubMed ID: 29154935
[TBL] [Abstract][Full Text] [Related]
59. Evodiamine ameliorates paclitaxel-induced neuropathic pain by inhibiting inflammation and maintaining mitochondrial anti-oxidant functions.
Wu P; Chen Y
Hum Cell; 2019 Jul; 32(3):251-259. PubMed ID: 30701373
[TBL] [Abstract][Full Text] [Related]
60. Trimethoxyflavanone relieves Paclitaxel-induced neuropathic pain via inhibiting expression and activation of P2X7 and production of CGRP in mice.
Mei C; Pan C; Xu L; Miao M; Lu Q; Yu Y; Lin P; Wu W; Ni F; Gao Y; Xu Y; Xu J; Chen X
Neuropharmacology; 2023 Sep; 236():109584. PubMed ID: 37225085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
